House Hearing on the FDA’s Regulation of Over-the-Counter Monograph Drugs

4 months ago
7

House Committee on Energy and Commerce, Subcommittee on Health hearing entitled, "Examining the FDA’s Regulation of Over-the-Counter Monograph Drugs."

Witnesses Include:
- Kevin Menzel, Member, Board of Directors, Consumer Healthcare Products Association; President, Focus Consumer Healthcare
- Douglas Troutman, Interim Co-Chief Executive Officer, American Cleaning Institute
- Kim Wezik, MPH, Director of Advocacy, Melanoma Research Foundation
- Scott Faber, Senior Vice President, Government Affairs, Environmental Working Group
- Carl D’Ruiz, MPH, Senior Science, Advocacy, and Business Development Manager for Beauty and Care, North America, dsm-firmenich

April 01, 2025.

Support The Union Herald
Patreon: https://www.patreon.com/TheUnionHerald

Follow The Union Herald
Facebook: https://www.facebook.com/TheUnionHerald
X: https://twitter.com/TheUnionHerald
Instagram: https://www.instagram.com/theunionherald
Threads: https://www.threads.net/@theunionherald
All Links: https://linktr.ee/TheUnionHerald

Loading comments...